This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $35,173.54 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 9, 2024 and was not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is part of that larger IDC contract with the DLA.
Generated 3/7/25, 9:53 AM